基本資料
種類: ETF
費用比率%: 0.80
資產淨值: 36.31
成立日期: 16/11/2022
 
分析
市值分佈:
96.88%
大市值
0.49%
中市值
0.91%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 14/11/2026 05:08) 總持有投資項目: 46  
0%
 
100%
     10大 (61.52%)
代號 名稱 佔比% ▼ 持有日期
LLYEli Lilly & Co21.7731/10/2026
ASNDAscendis Pharma A/S15.3230/09/2026
ARGXargenx SE4.7331/10/2026
PCVXVaxcyte3.3931/10/2026
INSMInsmed Incorporated3.0331/10/2026
NTRANatera2.9330/09/2026
GHGuardant Health2.7931/10/2026
RYTMRhythm Pharmaceuticals2.6731/10/2026
ISRGIntuitive Surgical2.5431/10/2026
GILDGilead Sciences2.3630/09/2026
UTHRUnited Therapeutics Corp2.3131/10/2026
RVMDRevolution Medicines2.3031/10/2026
WGSGeneDx Holdings Corp2.2030/04/2026
DHRDanaher Corp2.1830/09/2026
IDXXIDEXX Laboratories2.0331/10/2026
CORCencora1.8531/10/2026
ABBVABBVIE1.6531/10/2026
HQYHealthEquity1.5831/10/2026
ABVXAbivax SA1.5531/10/2026
PTCTPTC Therapeutics1.3831/10/2026
 1    2    3  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.